The weekly litigation news digest is live. Subscribe now

IP Verse

Functionalized Peptides As Antiviral Agents - EP4051265

The patent EP4051265 was granted to Enanta Pharmaceuticals on Aug 20, 2025. The application was originally filed on Jul 19, 2021 under application number EP21846991A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4051265

ENANTA PHARMACEUTICALS
Application Number
EP21846991A
Filing Date
Jul 19, 2021
Status
Granted And Under Opposition
Jul 18, 2025
Publication Date
Aug 20, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5508269
DESCRIPTIONUS5767068
DESCRIPTIONWO2005113580
DESCRIPTIONWO2006061714
DESCRIPTIONWO2018023054
DESCRIPTIONWO2018042343
DESCRIPTIONWO9843650
EXAMINATIONWO0208244
INTERNATIONAL-SEARCH-REPORTUS2006014821
INTERNATIONAL-SEARCH-REPORTWO2005113580
INTERNATIONAL-SEARCH-REPORTWO2018042343
SEARCHWO2018042343
SEARCHWO2021226546
SEARCHWO2021250648
SEARCHWO2021252644

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents